Our mission is to develop novel formulations for biological drugs enabling direct and exclusive delivery to diseased cells and tissues. Our concept for the oligonucleotide drug family of siRNAs creates a broad potential for this new generation of drugs, having recently emerged in the drug landscape.

Location

Facts & figures

  • Type of organization
    Private company
  • Year of foundation
    2020
  • Number of employees in Switzerland
    1-9

Key business

Keep browsing

You may also be interested in